World Health Organization (WHO)Verifizierter Account

"... What’s the best way to manage cases of severe disease? What ethical issues we need to be aware of in the way we do our research? To defeat this outbreak, we need answers to all those questions, and more"-@DrTedros #2019nCoV

"There are also tools we don’t have. We have no vaccine to prevent infections, and no proven therapeutics to treat them"-@DrTedros #2019nCoV

"Following the West African #Ebola outbreak, we developed the WHO R&D Blueprint – a strategy for developing drugs and vaccines before epidemics, and accelerating research and development activities during epidemics"-@DrTedros #2019nCoV

"We activated the R&D Blueprint team in early January to coordinate and facilitate information-sharing on research elements of the #2019nCoV response"-@DrTedros

"The R&D Blueprint identifies several known pathogens as priorities for research, but also includes scenarios for “pathogen x” – a previously unknown pathogen exactly like the one we are dealing with now"-@DrTedros #2019nCoV

"We hope that one of the outcomes of this meeting will be an agreed roadmap for research around which researchers and donors will align. The bottom line is solidarity, solidarity, solidarity"-@DrTedros #2019nCoV

"That is especially true in relation to sharing of samples and sequences. To defeat the #2019nCoV outbreak, we need open and equitable sharing, according to the principles of fairness and equity"-@DrTedros

"WHO remains committed to equitable access to health products for populations that need them, and will work to ensure that access is always part of all R&D efforts"-@DrTedros #2019nCoV